These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28520410)

  • 1. Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting.
    Raghuwanshi Y; Etayash H; Soudy R; Paiva I; Lavasanifar A; Kaur K
    J Med Chem; 2017 Jun; 60(12):4893-4903. PubMed ID: 28520410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
    Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
    J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer.
    Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA
    Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
    Śmiłowicz D; Slootweg JC; Metzler-Nolte N
    Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytically stable cancer targeting peptides with high affinity for breast cancer cells.
    Soudy R; Gill A; Sprules T; Lavasanifar A; Kaur K
    J Med Chem; 2011 Nov; 54(21):7523-34. PubMed ID: 21967660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).
    Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH
    Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells.
    Soudy R; Chen C; Kaur K
    J Med Chem; 2013 Oct; 56(19):7564-73. PubMed ID: 24028446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of targeting ligands against breast cancer cells.
    Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
    J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.
    Soudy R; Etayash H; Bahadorani K; Lavasanifar A; Kaur K
    Mol Pharm; 2017 Mar; 14(3):593-604. PubMed ID: 28157321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
    Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
    Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
    Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
    Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo.
    Hasanpourghadi M; Pandurangan AK; Karthikeyan C; Trivedi P; Mustafa MR
    Oncotarget; 2017 Apr; 8(17):28840-28853. PubMed ID: 28392503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1.
    Gürsoy RN; Çevik Ö
    Pharm Dev Technol; 2014 Jun; 19(4):486-90. PubMed ID: 23678858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding Specificity of Radiolabeled Cyclic Peptide 153Sm-DTPA-c(CGRRAGGSC) to MHCC97-H Human Liver Cancer Cells and its Antitumor Effects in vivo.
    Wu Q; He Y; Gu C; Jiang J; Zhou H; Zhou S
    Technol Cancer Res Treat; 2016 Dec; 15(6):NP1-NP9. PubMed ID: 26376696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of a Proapoptotic Peptide to EGFR-Positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR.
    Toyama K; Nomura W; Kobayakawa T; Tamamura H
    Bioconjug Chem; 2018 Jun; 29(6):2050-2057. PubMed ID: 29763296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
    Ichihara H; Okumura M; Tsujimura K; Matsumoto Y
    Anticancer Res; 2018 Oct; 38(10):5645-5654. PubMed ID: 30275183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
    Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
    Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.